Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy

Dexamethasone, a widely used corticosteroid, has recently been reported as the first drug to increase the survival chances of patients with severe COVID-19. Therapeutic agents, including dexamethasone, are mostly transported through the body by binding to serum albumin. Herein, we report the first s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:bioRxiv
Asıl Yazarlar: Shabalin, Ivan G., Czub, Mateusz P., Majorek, Karolina A., Brzezinski, Dariusz, Grabowski, Marek, Cooper, David R., Panasiuk, Mateusz, Chruszcz, Maksymilian, Minor, Wladek
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cold Spring Harbor Laboratory 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7386489/
https://ncbi.nlm.nih.gov/pubmed/32743572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.07.21.212704
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller